• Home
  • Search Results
  • Critical roles of phosphoinositides and NF2 in Hippo pathway regulation.

Critical roles of phosphoinositides and NF2 in Hippo pathway regulation.

Genes & development (2020-03-03)
Audrey W Hong, Zhipeng Meng, Steven W Plouffe, Zhijie Lin, Mingjie Zhang, Kun-Liang Guan

The Hippo pathway is a master regulator of tissue homeostasis and organ size. NF2 is a well-established tumor suppressor, and loss of NF2 severely compromises Hippo pathway activity. However, the precise mechanism of how NF2 mediates upstream signals to regulate the Hippo pathway is not clear. Here we report that, in mammalian cells, NF2's lipid-binding ability is critical for its function in activating the Hippo pathway in response to osmotic stress. Mechanistically, osmotic stress induces PI(4,5)P2 plasma membrane enrichment by activating the PIP5K family, allowing for NF2 plasma membrane recruitment and subsequent downstream Hippo pathway activation. An NF2 mutant deficient in lipid binding is unable to activate the Hippo pathway in response to osmotic stress, as measured by LATS and YAP phosphorylation. Our findings identify the PIP5K family as novel regulators upstream of Hippo signaling, and uncover the importance of phosphoinositide dynamics, specifically PI(4,5)P2, in Hippo pathway regulation.

Product Number
Product Description

Monoclonal ANTI-FLAG® M2 antibody produced in mouse, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)
Phenylmethanesulfonyl fluoride, ≥98.5% (GC)
Cholera Toxin from Vibrio cholerae, ≥90% (SDS-PAGE), lyophilized powder
Saponin, for molecular biology, used as non-ionic surfactant
Monoclonal ANTI-FLAG® M2-Peroxidase (HRP) antibody produced in mouse, clone M2, purified immunoglobulin, buffered aqueous glycerol solution
Monoclonal Anti-Vinculin antibody produced in mouse, clone hVIN-1, ascites fluid
Hydrocortisone, ≥98% (HPLC)
Insulin from bovine pancreas, γ-irradiated, BioXtra, suitable for cell culture, potency: ≥20 units/mg (USP units), lyophilized powder
3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole, 97%